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Abstract 
 
The objective of this study was to evaluate the performance of a low-cost method, the 
Thin Layer Agar (TLA), for the diagnosis of smear-negative patients. This prospective 
study  was  performed  in  Homa  Bay  district  Hospital  in  Kenya.  Out  of  1584  smear-
negative sputum samples, 212 were positive by Löwenstein-Jensen (LJ) (13.5%) and 220 
positive by TLA (14%). The sensitivity of LJ and TLA was 71% and 74 % respectively. 
TLA could become an affordable method for the diagnosis of smear-negative tuberculosis 
in resource-limited settings with results available within 2 weeks. 
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Prevalence of smear-negative pulmonary tuberculosis (TB) has been increasing in 
countries  with  high  HIV  incidence  especially  in  low-income  countries  where  many
 
patients  are  HIV/TB  co-infected  and  where  culture  of  M.  tuberculosis  is  often  not 
available  (3,  4,  6,  13,  15).  Incidence  of  TB  in  Kenya  is  estimated  at  384/100  000 
inhabitants (23). Kenya ranks 13
th on the World Health Organisation (WHO) list of the 
22 high-burden countries for TB worldwide and HIV prevalence in new TB cases is 
estimated at 52% (23). Culture is more sensitive than smear microscopy (1, 3, 7), but 
Löwenstein-Jensen (LJ) medium is very slow. The Thin  Layer Agar (TLA) has been 
described  as  a  simple,  rapid  and  inexpensive  method  (11,  12,  18)  allowing  initial 
identification of M. tuberculosis based on colony morphology visualized microscopically, 
and by incorporation of para-nitrobenzoic acid (PNB) in the medium (10, 17, 19). We 
performed  a  prospective  study  to  evaluate  the  performance  of  the  TLA  method  for 
detection of M. tuberculosis in smear-negative samples as compared to cultivation in LJ 
medium.  
The  study  was  conducted  in  Homa  Bay  district  Hospital,  Kenya.  All  smear-
negative respiratory samples from suspect TB patients received between November 2007 
and  September  2008  were  included.  A  total  of  1584  smear-negative  samples  were 
analyzed.  Sputum  was  digested  and  decontaminated  using  the  sodium  hydroxide–N-
acetyl-L-cysteine (NaOH/NALC) method (9). LJ was examined twice weekly up to 8 
weeks  (22).
  Cultures  were  considered  positive  for  M.  tuberculosis  according  to  their 
morphological characteristics, a positive acid-fast bacilli (AFB) staining, and inhibition 
of  growth  by  PNB  performed  on  TLA  (8).  A  culture  was  considered  negative  if  no 
growth  was  observed  after  8  weeks,  and  was  considered  contaminated  if  there  was 
growth but was negative for AFB.  TLA plates were prepared as previously described 
(18) with small modifications. One hundred µl of decontaminated sample was inoculated 
on  a  bi-plate  Petri  dish  of  100mm  x  15mm  (Becton  Dickinson,  Sparks,  MD  USA) 
containing 20 ml of 7H11 agar supplemented  with 10% OADC (oleic acid, albumin, 
dextrose  and  catalase)  (Becton  Dickinson)  plus  piperacillin,  trimethoprim  and 
amphotericin B (Sigma Aldrich) at 0.05 µg/ml, 0.02 µg/ml and 0.02 µg/ml respectively. 
PNB at 500 µg/ml was incorporated in one compartment. The plates were sealed with 
sterile parafilm leaving a space of 1-2 cm and incubated at 37°C in 5% CO2. Plates were 
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checked after 24 hours for contamination and examined twice weekly up to 6 weeks 
using a standard microscope. A positive culture was identified by the characteristic cord 
of M. tuberculosis growth. Non-tuberculous mycobacteria (NTM) were recognized by 
their  lack  of  cording  and  growth  on  PNB.  Fungal  or  bacterial  contamination  was 
recognized by rapid overgrowth of the plates.  
The reference standard was considered when a sample was positive in any of the two 
culture media, TLA or LJ. Sensitivity was calculated as the number of positive cultures 
on LJ or TLA divided by the total number of positive cultures in any culture media. The 
Wilcoxon test for non-normal distribution was applied to compare differences in time to 
detection between the two culture media; paired comparisons were performed excluding 
contaminated specimens. A P value < 0.05 was considered to be statistically significant. 
Analysis  was  performed  with  MedCalc®  version  9.6.4.0  (MedCalc  Software, 
Mariakerke, Belgium). The time to detection of growth and contamination rates were 
recorded for each culture medium. 
Out of 1584 smear-negative samples, 212 were positive by LJ (13.5%) and 220 positive 
by TLA (14%). All positive cultures were presumptively identified as M. tuberculosis.  
Eight  NTM  isolates  were  identified  by  growth  on  PNB,  morphology  and  colony 
pigmentation and molecular identification was performed at the Reference TB laboratory 
in Antwerp, Belgium for final confirmation. The NTM found were M. gordonae, M. 
flavescens and M. kubicae. Out of the 1584 samples, 1099 (69.5 %) were culture negative 
by LJ and 951 (60%) by TLA.  Two-hundred and five (17%) samples inoculated on LJ, 
and 325 (26%) of TLA were contaminated. The sensitivity of LJ was 71% and 74 % for 
TLA. The median time to growth was 23 days for LJ and 14 days for TLA (P<0.0001). 
Among the positive cultures, the combination of both media increased the positivity. One 
hundred and thirty five positive cultures on LJ were also found positive on TLA. Forty 
seven positive cultures found on LJ were negative on TLA, and 30 positive cultures on LJ 
were found contaminated on TLA. For TLA, 47 positive cultures were found negative on 
LJ and another 38 positive cultures were found contaminated on LJ. Figure 1 shows the 
average time to obtain a positive culture on LJ and TLA. More than 70% of cultures were 
found positive between 8 and 14 days on TLA while the majority of cultures were found 
positive on LJ between 15 and 22 days and after 23 days. Figure 2 shows a typical cord 
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formation characteristic for M. tuberculosis on TLA (picture A) and cords together with 
contaminants (picture B). 
This is the first operational study performed in a low-income country, in a rural 
setting,  that  demonstrates  that  the  TLA  method  performed  as  well  as  the  LJ  for  the 
diagnosis of smear-negative samples, having a higher speed for results than culture on LJ. 
All  reagents  were  available  from  local  suppliers.  TLA  was  able  to  differentiate 
presumptively  between  M.  tuberculosis  complex  and  NTM  which  is  an  advantage 
compared to LJ. The support of other facilities for complete species identification is still 
required. Another method called the microscopic observation drug susceptibility (MODS) 
assay (14) is similar to TLA, but the disadvantage is the use of liquid medium and the 
need of an inverted microscope. Contamination was a serious problem in our study and 
caused the loss of several samples. The rate of contamination was 17% for LJ and 26% 
for TLA. We have to point out that contamination was high in both media not only in 
TLA. The concentration of NaOH used in the decontamination was 2% but could be 
increased up to 4% to attempt reducing contamination.  However, care should be taken to 
avoid the toxicity for mycobacteria that may cause negative culture results (21). Another 
important point could be the delay between sputum collection and processing, but in this 
study,  it  was  only  2-3  days  and  samples  were  kept  at  4°C.  Concerning  antibiotic 
mixtures,  they  are  frequently  used  to  inhibit  the  growth  of  contaminants  and  the 
concentration of piperacillin, trimethoprim and amphotericin B used in this study could 
be increased, since they were rather low. Preliminary results using a concentration of 4.0 
µg/ml of the three antibiotics showed that the contamination rate in TLA decreased to 
less  than  10%  (Martin  et  al.,  unpublished).  Piperacillin  is  active  against  many  gram-
positive and negative bacteria, trimethoprim is a bacteriostatic agent, and amphotericin B 
is  an  antifungal  drug.  The  most  common  contaminants  were  Candida  albicans, 
coagulase-negative Staphylococcus, Staphyloccocus aureus, Pseudomonas species, and 
Aspergillus.    Since  some  contamination  was  due  to  S.  aureus,  one  possibility  is  the 
addition  of  vancomycin  to  TLA  to  reduce  this  contamination.  We  noticed  that  the 
contamination rate decreased slowly during the study. Such improvement suggests the 
need  to  set  up  a  training  period  during  which  technicians  can  become  familiar  with 
culture to easily recognize cord specific of M. tuberculosis. In the few published studies 
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using TLA, the contamination rate was reported as 5-16% (2, 11, 12, 18). However, those 
studies were carried out in reference laboratories in middle-income countries with smear-
positive  contrary  to  the  present  study  performed  in  rural  laboratory  in  a  low-income 
country on smear-negative samples.  Concerning the workload, in Homa Bay, an average 
of ten samples per day is inoculated into both media in duplicate. At least two technicians 
should be dedicated full time to prepare the media, registration of data, decontamination, 
inoculation  and  reading  of  TLA  plates  and  LJ  tubes.  A  cost-effectiveness  study  is 
ongoing to evaluate the impact of the introduction of the TLA to diagnose TB in smear-
negative patients. Despite the high contamination rate found in both media, we believe 
that TLA could be implemented in TB/HIV settings to increase the TB case detection in 
smear-negative. TLA is faster than conventional culture, practical and inexpensive and 
allows the presumptive identification of M. tuberculosis complex. Smooth variants of M. 
tuberculosis have been described and named M. canettii (20). These variants are however 
infrequent and have been found only until now in the horn of Africa (16). TLA provides 
an alternative method when more sophisticated techniques are not available or affordable 
to implement.  
 
We would like to thank all the MSF-F team in Homa Bay and Nairobi, local and expat personnel 
that gave support to this study. Thanks to Dr. Juan Carlos Palomino for critically reviewing the 
manuscript.  
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Figure 1.   
Time to detection (days) of M. tuberculosis culture positive results in TLA and in LJ 
medium 
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Figure 2. 
Micro-colonies of M. tuberculosis in TLA seen under microscope (10x objective).  
A: characteristic cord formation of M. tuberculosis. B: cord and contamination (filament) 
together. 
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